Tecan uses cookies to improve our website. By continuing to browse our website, you accept our cookie policy.

Daniel R. Marshak

Dr. Daniel R. Marshak

Member of the Compensation Committee
Since 2018, elected until 2022
1957, US-American citizen

Education Ph.D in Biochemistry and Cell Biology, The Rockefeller University, New York, USA; Bachelor in Biochemical Sciences, Harvard University, Cambridge, USA
Professional background
2014 to present Consultancy for various companies in the Life Sciences, Bio-Pharmaceutical, and Diagnostics industry. Consultant to RADx program of US Government DHHS/NIH/NIBIB for COVID-19 diagnostics
2006 – 2014 PerkinElmer, Inc., USA (NYSE: PKI)
In his last role as Senior Vice President and Chief Scientific Officer, he was responsible for all science and technology as well as research and development activities and also led several acquisitions during that time.
Additional positions at PerkinElmer:
President, Emerging Diagnostics, Waltham, USA and Shanghai, China
President, Greater China, Shanghai, China
2000 – 2006 Cambrex Corporation, USA (NYSE: CBM)
Vice President and Chief Technology Officer, Biotechnology
Vice President Research and Development, Biosciences
1994 – 2000 Sr. Vice President and Chief Scientific Officer, Osiris Therapeutics, Inc
1986 – 1995 Cold Spring Harbor Laboratory, USA
Sr. Staff Investigator
1984 – 1986 Staff Fellow, National Institutes of Health, USA
Other activities
RareCyte, Inc. 2, Member of the Board of Directors; InVivo Therapeutics Corp1, Member of the Board of Directors; LifeVault Bio Inc. 2, Member of the Board of Directors; Elevian Inc. 2, Member of the Board of Directors.


1 public company
2 private company